CytomX | SC 13G/A:超过5%持股股东披露文件(修正)-BVF Partners L.P.(9.99%),BVF Inc.(9.99%)等
CytomX | SC 13G/A:超过5%持股股东披露文件(修正)-Tang Capital Management, LLC(9.99%),Kevin Tang(9.99%)等
CytomX | SC 13G/A:超过5%持股股东披露文件(修正)-Cormorant Asset Management, LP(0%),Bihua Chen(0%)
CytomX | SC 13G/A:超过5%持股股东披露文件(修正)-Janus Henderson Group plc(6.2%),Janus Henderson Biotech Innovation Master Fund Ltd(6.2%)
CytomX | 4:持股变动声明-高管 Landau Jeffrey B
CytomX | 4:持股变动声明-高管 BELVIN MARCIA
CytomX | 4:持股变动声明-高管 ROWLAND LLOYD A
CytomX | 4:持股变动声明-高管 Ogden Christopher
CytomX | 4:持股变动声明-高管 McCarthy Sean A.
CytomX | 4:持股变动声明-高管 Ogden Christopher
CytomX | SC 13G:超过5%持股股东披露文件-Janus Henderson Group plc(5.3%),Janus Henderson Biotech Innovation Master Fund Ltd(5.3%)
CytomX | 4:持股变动声明-董事 Su Zhen
CytomX | 4:持股变动声明-董事 Young Matthew P.
CytomX | 4:持股变动声明-董事 Mohindru Mani
CytomX | 4:持股变动声明-董事 Meyers James R
CytomX | 4:持股变动声明-董事 Jones Elaine V
CytomX | 4:持股变动声明-董事 Ashworth Alan
CytomX | 4:持股变动声明-董事 Gilbert Halley E
CytomX | SC 13G:超过5%持股股东披露文件-Cormorant Global Healthcare Master Fund, LP(7.38%),Cormorant Global Healthcare GP, LLC(7.38%)等
CytomX | 4:持股变动声明-高管 McCarthy Sean A.